Notification and current-status evidence
The sent-report ledger records the first outgoing report at .
The recorded recipient is abuse@trustname.com.
The latest stored availability evidence still shows the domain reachable; 3 months has elapsed since the first outgoing report.
ICANN RAA §3.18 describes registrar abuse-contact and handling obligations. This section records outgoing timestamps, listed recipients, case identifiers, and later availability. It does not by itself prove receipt, acknowledgement, investigation, remediation, or contractual non-compliance.
globalpharmacare[.]net
“Global Pharma Care Provides Relief From Muscle Spasms & Pain”
globalpharmacare.net — Não verificado. Resumo das evidências: VirusTotal 2/91 (Gridinsoft, SOCRadar); URLQuery 1 alert; PhishDestroy score 76/100. Registrador: Fewmoretaps OU d/b/a T….
A análise detalhada do PhishDestroy AI permanece em inglês para preservar o registro forense original.
The domain globalpharmacare.net has been identified as a generic phishing threat, currently taken offline. The page title, "Global Pharma Care Provides Relief From Muscle Spasms & Pain," suggests an attempt to impersonate a pharmaceutical company, though no specific brand is named in the available data. This domain was created on April 28, 2026, and registered through Fewmoretaps OU d/b/a Trustname.com. It resolves to IP address 188.114.97.3 and uses an SSL certificate issued by Google Trust Services / WE1. The domain is flagged by 2 out of 95 VirusTotal security vendors and appears on one security blocklist. Additionally, it was found in one threat intelligence pulse on AlienVault OTX. Given its elevated risk level and malicious intent, the domain has been taken offline. PhishDestroy recommends that organizations block this domain and any associated IP addresses. Users should avoid interacting with any content from this domain and report any related emails or links to their security team. Continuous monitoring for similar domains is advised to prevent future phishing attempts.
Sinais de segurança
Inteligência de segurança de rede Registrar context
| Detection System | Indicator | Verdict | Alert |
|---|---|---|---|
| DNS4EU | globalpharmacare.net |
malicious | Sinkholed |
Pipeline de resposta a ameaças
Status da lista de bloqueios pública
Captura armazenada
Inteligência de Domínios
Detalhes técnicosDNS, SANs do SSL, carimbos de data e hora
ICANN OVERSIGHT
Credenciamento e contexto RAA
Credenciamento e contexto RAA
Registrar accreditation and DNS abuse obligations
For this gTLD, the registrar above operates under an ICANN accreditation agreement. The links below provide the official fee schedule and current DNS abuse compliance guidance.
Accreditation is a contract, not a safety certification.
RAA §3.18 establishes abuse-contact and handling requirements. This report can document stored outbound notices and later technical observations; it does not by itself establish receipt, investigation, remediation, or contractual non-compliance.
Análise do VirusTotal
Análise de desempenho do site
Google PageSpeed Insights — mobile performance audit of globalpharmacare.net · checked Apr 30, 2026
Evidências e relatórios externos
PD-20260428-B9D82C Recipient: abuse@trustname.com Você foi afetado por este site?
Se você inseriu credenciais de conta, informações pessoais ou de pagamento, ou baixou um arquivo deste domínio, tome medidas imediatas. Abaixo estão os recursos para ajudá-lo a relatar o incidente e se proteger.
Notifique as autoridades locais
Selecione seu país para obter contactos oficiais do cibercrime ou crie um rascunho de reclamação →.
Verificar qualquer domínio
Análise de ameaças usando lista de bloqueio armazenada, WHOIS, DNS e evidências de verificação pública
Digitalize agoraDenunciar phishing
Envie domínios suspeitos para nosso banco de dados de ameaças — proteja a comunidade
DenunciarFeed de ameaças em tempo real
Relatórios recentes de phishing e alterações de disponibilidade observadas
MonitorarMantenha-se informado, mantenha-se seguro
Monitore ameaças em tempo real ou conteste esta listagem caso acredite que se trate de um falso positivo